Anthem Biosciences Limited - Company Profile

Q: Who are the current directors of Anthem Biosciences Limited?

The current directors of Anthem Biosciences Limited are Ganesh Sambasivam, Ajay Bhardwaj, Shubha Kulkarni, K Ravindra Chandrappa, Ramadurai Ramesh, Satish Chander Subbanna, Subramanian Madhavan, Ravikant Uppal, Ajay Bhardwaj, Divya Prasad, Mohammed Gawir Baig.

It is a pharma public limited company based in Bangalore, Karnataka, India, established in 2006.

2006 Bangalore, Karnataka, India Active

Last Updated: January 08, 2026

Access Report

About Anthem Biosciences Limited

Anthem Biosciences Limited, a active public limited company, was established on 13 June 2006 in Bangalore, Karnataka, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: L24233KA2006PLC039703. Registered under ROC Roc Bangalore. it is listed. It has an authorized capital of ₹125.00 Cr and a paid-up capital of ₹112.32 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹1,488.06 Cr and a net worth of ₹1,933.07 Cr. Employing 1,876 professional, Its leadership includes Ganesh Sambasivam (Whole-Time Director), Ajay Bhardwaj (Managing Director), Shubha Kulkarni (Director). Past directors included Ganesh Sambasivam, K Ravindra Chandrappa, Mohammed Gawir Baig. It holds ₹311.21 Cr open charges and ₹484.38 Cr settled loans. Its latest AGM occurred on 10 June 2025, with the balance sheet filed on 31 March 2025. It is based at No. 49, F1 & F2, Canara Bank Road Bommasandra Industrial Area, Phase I, Bo, Mmasandra, Bangalore, Karnataka, 560099.

Company Details

CIN/LLPIN
L24233KA2006PLC039703
Registration Number
039703
Incorporation Date
13 June 2006
Authorized Capital
₹125.00 Cr
Paid-Up Capital
₹112.32 Cr
ROC Code
Roc Bangalore
Listing Status
Listed
Company Status
Active

Key Metrics

Authorised Capital ₹ 125.00 Cr as on 08-01-2026
Paid Up Capital ₹ 112.32 Cr as on 08-01-2026
Company Age 19 Year, 7 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 311.21 Cr as on 08-01-2026
Satisfied Charges ₹ 484.38 Cr as on 08-01-2026
Revenue Growth **** 31.19% (FY 2024)
Profit Growth **** -2.82% (FY 2024)
Ebitda **** 17.69% (FY 2024)
Net Worth 10.99% (FY 2024)
Total Assets **** 16.62% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Anthem Biosciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Anthem Biosciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ganesh Sambasivam	Whole-Time Director	04 Aug 2006	Current
Ajay Bhardwaj	Managing Director	13 Jun 2006	Current
Shubha Kulkarni	Director	27 Sep 2024	Current
K Ravindra Chandrappa	Whole-Time Director	27 Sep 2006	Current
Ramadurai Ramesh	Director	27 Sep 2024	Current
Satish Chander Subbanna	Nominee Director	09 Apr 2021	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	09 Jun 2025	Past
Pramod Abcsdd	Director	09 Jun 2025	Past
Pramod Abcsdd	Cfo	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Anthem Biosciences.

Anthem Biosciences Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 31.19% increase. The company also saw a slight decrease in profitability, with a 2.82% decrease in profit. The company's net worth Soared by an impressive increase of 10.99%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

31.19%

*******

Revenue from Operations

*******

34.12%

*******

Total Assets

*******

16.62%

*******

Profit or Loss

*******

-2.82%

*******

Net Worth

*******

10.99%

*******

EBITDA

*******

17.69%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Anthem Biosciences?

In 2024, Anthem Biosciences had a promoter holding of 76.70% and a public holding of 23.30%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹3,112,110,685.00

Satisfied Charges

₹4,843,800,000.00

Charges Breakdown by Lending Institutions

Citi Bank N.A. : 275.00 Cr
Hdfc Bank Limited : 25.00 Cr
Others : 11.21 Cr

Latest Charge Details

Date	Lender	Amount	Status
15 Sep 2022	Citi Bank N.A.	₹125.00 Cr	Open
16 May 2017	Hdfc Bank Limited	₹25.00 Cr	Open
14 Feb 2017	Others	₹11.21 Cr	Open
26 May 2014	Citi Bank N.A.	₹150.00 Cr	Open
16 Feb 2023	Others	₹204.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Anthem Biosciences?

Anthem Biosciences has a workforce of 1876 employees as of Sep 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Anthem Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anthem Biosciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Anthem Biosciences

Recent Activity within the Organization

Annual General Meeting

Progress on Anthem Biosciences Limited last Annual general meeting of members was held on 10 Jun 2025 as per latest MCA records. was documented.
10 Jun 2025
Charges

The activity A charge registered on 16 Feb 2023 via Charge ID 100684784 with Others was fully satisfied on 23 Apr 2025. was completed.
23 Apr 2025
Balance Sheet

Anthem Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
31 Mar 2025
Charges

The activity A charge with Citi Bank N.A. of Rs. 150.00 Cr registered on 26 May 2014 with Charge ID 10508137 was modified on 05 Mar 2025. was completed.
05 Mar 2025
Director Appointment

Ajay Bhardwaj was appointed as a Ceo was appointed as a Ceo on 20 Dec 2024 & has been associated with this company since 1 year 1 month . was recorded as a recent event.
20 Dec 2024
Director Appointment

The activity Shubha Kulkarni was appointed as a Director was appointed as a Director on 27 Sep 2024 & has been associated with this company since 1 year 4 months . was completed.
27 Sep 2024

Explore recent activity and updates - View Recent Activity